LCD for Obesity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
ObesityLCD - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a low-carb diet to see how it affects weight, heart health, and blood sugar.

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: baseline to 6 months

baseline to 6 months
Change in LDL-C
Change in adiposity
Change in metabolic flexibility
Change in small dense low-density lipoprotein
Change in total cholesterol
Change in weight

Trial Safety

Trial Design

2 Treatment Groups

Standard Dietary Advice Control Group
1 of 2
Low Carbohydrate Diet
1 of 2

Active Control

Experimental Treatment

50 Total Participants · 2 Treatment Groups

Primary Treatment: LCD · No Placebo Group · N/A

Low Carbohydrate Diet
Behavioral
Experimental Group · 1 Intervention: LCD · Intervention Types: Behavioral
Standard Dietary Advice Control Group
Behavioral
ActiveComparator Group · 1 Intervention: Control · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LCD
2007
Completed Phase 3
~340

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 6 months

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
625 Previous Clinical Trials
365,722 Total Patients Enrolled
27 Trials studying Obesity
5,593 Patients Enrolled for Obesity
Mohammad Siddiqui, MDPrincipal InvestigatorVirginia Commonwealth University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
, repeat lumbar MRI At least 12 months after a patient undergoes an lumbar MRI, a repeat MRI should be done.